Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2005
05/06/2005WO2004106508A3 Bioreactor containing cells expressing glycosyltransferase nucleic acids
05/06/2005WO2004099381A3 Genetically modified yeast species and fermentation processes using genetically modified yeast
05/06/2005WO2004093785A3 Rhesus monkey bombesin receptor subtype-3 (brs-3), nucleotides encoding same, and uses thereof
05/06/2005WO2004090141A3 Method to increase stress tolerance in plants
05/06/2005WO2004081533A3 Vault and vault-like carrier molecules
05/06/2005WO2004080419A3 Humanized antibodies that recognize beta amyloid peptide
05/06/2005WO2004080418A3 Nucleic acid compounds for inhibiting angiogenesis and tumor growth
05/06/2005WO2004078949A3 Genes of an otitis media isolate of nontypeable haemophilus influenzae
05/06/2005WO2004078933A3 Intracellular delivery of small molecules proteins and nucleic acids
05/06/2005WO2004078776A3 Ny-eso-1 peptides which bind to class ii molecules and uses thereof
05/06/2005WO2004058815B1 Centrosome-associated protein and applications thereof
05/06/2005WO2004052933B1 Peptide oligomers for use as hiv vaccines
05/06/2005WO2004041889A3 Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
05/06/2005WO2004018619A3 P53 binding t cell receptor molecules and uses thereof
05/06/2005WO2003102146A3 Aptamer constructs
05/06/2005WO2003068146A3 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
05/06/2005WO2003062394A3 Methods and compositions for rna interference
05/06/2005WO2003057840A3 Compositions for dna mediated gene silencing
05/06/2005WO2003010286A3 Nucleic acids, polypeptides, and methods for modulating apoptosis
05/06/2005WO2002072787A3 Telomerase expression repressor proteins and methods of using the same
05/06/2005CA2826733A1 High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of mar sequences
05/06/2005CA2547514A1 Method for screening genomic dna fragments
05/06/2005CA2543789A1 Detection of mutations in a gene associated with resistance to viral infection, oas1
05/06/2005CA2543786A1 Methods and systems for inferring traits to manage non-beef livestock
05/06/2005CA2543565A1 Use of caspase-8 inhibitors for modulating hematopoiesis
05/06/2005CA2543360A1 Ldl receptor class a and egf domain monomers and multimers
05/06/2005CA2543329A1 Orthogonal gene switches
05/06/2005CA2543200A1 Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism
05/06/2005CA2543189A1 In vivo gene therapy of parkinson's disease
05/06/2005CA2543002A1 Method for inducing a specific rnai activity in cells and nucleic acids for carrying out said method
05/06/2005CA2542942A1 Nucleic acids useful for triggering tumor cell lethality
05/06/2005CA2542924A1 Msp-3-like family of genes
05/06/2005CA2542922A1 Protein expression
05/06/2005CA2542708A1 Dna delivery with gemini cationic surfactants
05/06/2005CA2542686A1 Colorectal cancer antigen
05/06/2005CA2542426A1 Methods, compositions and devices for inducing stasis in cells
05/06/2005CA2542239A1 Multispecific deimmunized cd3-binders
05/06/2005CA2542053A1 Dna cloning vector plasmids and methods for their use
05/06/2005CA2542017A1 Vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives
05/06/2005CA2541864A1 Process for preparing enantiomer-enriched alpha-hydroxycarboxylic acids and amides
05/06/2005CA2541523A1 Minimal dna sequence acting as a chromatin insulator and its use in protein expression
05/06/2005CA2541280A1 Modified cdna for high expression levels of factor viii and its derivatives
05/06/2005CA2541141A1 Trans-2-enoyl-coa reductase gene of euglena gracilis
05/06/2005CA2540023A1 Hepatocellular carcinoma specific promoter and uses thereof
05/06/2005CA2536078A1 Rnai-based modification of heterochromatin
05/06/2005CA2536026A1 Eukariotic expression systems for expression of inhibitory rna in multiple intracellular compartments
05/06/2005CA2535836A1 High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of mar sequences
05/06/2005CA2534996A1 The use of sirna silencing in the prevention of metastasis
05/06/2005CA2534828A1 Novel cxcl8 antagonists
05/06/2005CA2532094A1 Sp1 and sp3 targeted cancer therapies and therapeutics
05/06/2005CA2530738A1 Prediction of likelihood of cancer recurrence
05/05/2005US20050097641 Transformation method for obtaining marker-free plants and plants obtained therewith
05/05/2005US20050097640 Expression vector comprising nucleotide sequences coding cold shock protein for use in transforming and generating freeze resistant plants
05/05/2005US20050097639 Abiotic stress tolerance protein for use as tool in generating drought resistant crop plants
05/05/2005US20050097638 Transcriptional regulation of plant biomass and abiotic stress tolerance
05/05/2005US20050097637 Transgenic plants compromising nucleic acid molecules encoding RAR 1 disease resistance proteins and uses thereof
05/05/2005US20050097636 OAR polynucleotides, polypeptides and their use in PHA production in plants
05/05/2005US20050097635 Nucleotide sequences coding crystal protein for use in generating insect resistant crop plants; biological pest control
05/05/2005US20050097634 Methods of increasing polypeptide accumulation in plants
05/05/2005US20050097633 Plasmid comprising plant regulatory sequences for use in enhancing expression of heterologous gene; generating disease, insect, drought and herbicide resistant plants
05/05/2005US20050097632 Phenotype modifying genetic sequences
05/05/2005US20050097631 Transgenic plants
05/05/2005US20050097627 Transgenic ungulates having reduced prion protein activity and uses thereof
05/05/2005US20050097625 Generating trangenic mammal in which somatic and germ cell comprisie heavy chain variable region of immunoglobulins; bioreactors for production of preferential immunoglobulins in milk
05/05/2005US20050096463 Metastasis inducing DNA's
05/05/2005US20050096462 Novel human neurexin-like proteins and polynucleotides encoding the same
05/05/2005US20050096461 growth hormone supergene family; prolongs circulating half-lives of protein therapeutics in the body so proteins do not have to be injected frequently; adding cysteine residues to non-essential regions using site-directed mutagenesis; covalently coupling a cysteine-reactive polymer via the added cysteine
05/05/2005US20050096460 Beta-amyloid peptide-binding proteins and polynucleotides encoding the same
05/05/2005US20050096459 Oligomeric receptor ligand pair member complexes
05/05/2005US20050096458 GENSET polynucleotides and polypeptides used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, expression vectors production; screening/diagnosis assays for abnormal GENSET expression and/or biological activity; gene therapy; genomics
05/05/2005US20050096457 Peptide substrates and fusion polypeptide substrates comprising a beta -secretase cleavage site wherein a human Aspartyl protease cleaves the peptide between P1 and P1, the rate of which cleavage is used to identify modulators of Alzeimer's disease, neurofibrillary tangles, gliosis and neuronal loss
05/05/2005US20050096292 Antisense oligonucleotides for apotopsis and chimera and expression of Notch 1
05/05/2005US20050096291 Method of inhibition of flavivirus to prevent and cure viral diseases by administering nucleotides
05/05/2005US20050096290 Treatment of diseases with aptamers with inverted nucleotide capped ends for treatment of neovascularization related diseases like age related macular degeneration
05/05/2005US20050096288 Antigen specific immune response by providing low density lipoprotein and a nucleic acid to be expressed as antigen bonded to each other for genes in vaccines
05/05/2005US20050096287 Enhance delivery of oligonucleotides, nucleosides, nucleic acids by injection or applying on skin a solution in water
05/05/2005US20050096285 Novel amino acid sequences, DNA encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
05/05/2005US20050096284 RNA interference mediated treatment of polyglutamine (polyQ) repeat expansion diseases using short interfering nucleic acid (siNA)
05/05/2005US20050096282 Ribozymes and eye diseases, viruses and kits, macular degeneration or retinitis
05/05/2005US20050096277 Methods of prevention and treatment using apolipoprotein analogues
05/05/2005US20050096269 Protein Cluster II
05/05/2005US20050096268 Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
05/05/2005US20050096265 Characterization of a membrane estrogen receptor
05/05/2005US20050096257 Administering platelet derived growth factor antagonist and endothelial growth factor antagonist
05/05/2005US20050095713 Vectors for gene mutagenesis and gene discovery
05/05/2005US20050095712 Mutations caused by activation-induced cytidine deaminase
05/05/2005US20050095710 Antisense modulation of PTP1B expression
05/05/2005US20050095709 Compositions and methods for inhibiting translation of a chimeric gene
05/05/2005US20050095707 Using mixture comprising embryonic stem cells, neurotrophins and either cyclic adenosine monophosphate (cAMP) to propagate nervous system tissues for use in treatment of neurodegenerative disorders; regenerative medicine; tissue engineering
05/05/2005US20050095705 Cell comprising replication-competent adenovirus vector for use as tool in generating gene therapeutic vectors; tissue directed therapy
05/05/2005US20050095704 Using nuclear transplantaion to transfer preferential nuclear material into enucleated animal oocyte; tissue engineering; gene therapy
05/05/2005US20050095701 Transplanting conditionally-immortalized dorsal root ganglion progenitor cells into mammal to generate peripheral nervous system (PNS) for treatment and prevention of nervous system disorders
05/05/2005US20050095689 Plant protein for use in enhancing ability to absorb insoluble iron in soils and for improving resistance to iron deficiency in plants
05/05/2005US20050095688 Process for the preparation of L-amino acids using strains of the family Enterobacteriaceae
05/05/2005US20050095687 Process for the preparation of L-amino acids using strains of the family enterobacteriaceae
05/05/2005US20050095683 Bacillus serine proteases for use as active agent in cleaning compounds and detergents
05/05/2005US20050095682 Campylobacter polypeptides and methods of use
05/05/2005US20050095681 Intracellular modulators of apoptopic cell death pathways
05/05/2005US20050095678 Novel rat calcium channel subunits and related probes, cell lines and methods
05/05/2005US20050095675 Mucin peptide with immunoenhancing properties
1 ... 2030 2031 2032 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 2043 2044 2045 2046 2047 2048 2049 2050 ... 4023